Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. . – July 28, 2021) – PharmaDrug Inc.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Canna Law Blog

FEBRUARY 24, 2020

Psilocybin has been in the news with increasing frequency as research into psychedelic therapy has proliferated, and a number of local jurisdictions, including the cities of Oakland, Denver , and Santa Cruz have decriminalized psilocybin to varying degrees. Currently: Eligible for signature collection.

Decriminalization 145

Decriminalization Therapy Research and Development Treatment 145

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

NOVEMBER 22, 2019

She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and researcher under a contract with NHTSA and NORC on the topic of the prosecution of drugged driving cases. There are newly developing alternative testing devises that use oral fluid and drug breathalyzers. uid is collected.” [ix]

Research and Development 71

Research and Development Law Collective Concentrates 71

LifeCannMD

AUGUST 30, 2024

Cannabis research related to PTSD (post-traumatic stress disorder) is a growing field. We continue to learn more and more as research funding is becoming available and laws are allowing for more studies to be conducted. Some researchers hypothesize that cannabis could potentially help modulate this system to alleviate PTSD symptoms.

Marijuana 110

Marijuana Research and Development Treatment THC 110

Cannabis Law Report

JULY 19, 2021

We don’t want to see research fall to the wayside as it has for cannabis, both in Canada and globally. We are in a mental health crisis and its critical to ensure that we conduct clinical trials to demonstrate safety, and efficacy up to and including phase 3 large scale clinical trials.

Clinical Trials 75

Clinical Trials Research and Development Hybrid Medicine 75

Cannabis Law Report

AUGUST 22, 2021

But for now, the developers are focused on creating a training that emphasizes compassionate response, de-escalation, and the safety and well-being of individuals having a challenging time with a psychedelic experience. Interesting piece from Lucid news. Read the full report at .

Research and Development 105

Research and Development Decriminalization Education Safety 105

Veriheal

JANUARY 16, 2024

Let’s take a closer look at this new research around CBD for Cerebral Palsy and examine the extent of this trend and its implications for the future of CP management. It occurs due to abnormalities or damage to the developing brain before, during, or after birth. What is Cerebral Palsy?

Patients 116

Patients CBD Treatment Research and Development 116

The Blunt Truth

MAY 15, 2020

We’ve got an update on the latest Montana legalization developments. marijuana research. We reported last week on the DOJ’s memo finding that the Drug Enforcement Administration’s cannabis research program is non-compliant with international drug laws. SBA funds, however, are not. montana update. montana update.

Banking 106

Banking Research and Development Programs Advocacy 106

Cannabis Law Report

SEPTEMBER 9, 2021

WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHEN: Cross Channel Measurement in a Time of Data Collection Challenges. . 20, 2021, from 2:40 – 2:55 p.m.

Events 78

Events Wellness and Beauty Data Media 78

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Validcare contracted with 17 CBD companies and acted as the Contract Research Organization, which included gaining feedback from FDA on the protocol, conducting the study and publishing its results.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

MAY 18, 2022

NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The study abstract is available here. The methods for both phases were the same.

Safety 52

Safety Hemp Research and Development Data 52

Puff Puff Post

MARCH 10, 2020

“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of Clinical Development & Regulatory Affairs. For more information, visit www.inmedpharma.com.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

JANUARY 31, 2022

TSX-V:NUMI, OTC:LKYSF) said that its research facility– Numinus Bioscience– has been included on Health Canada’s list of federally licensed psilocybin producers. This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. Numinus Wellness Inc.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. About RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

DECEMBER 1, 2021

Ethics, Safety, and Abuse in Psychedelic Medicine. Allison Feduccia, PhD is a neuropharmacologist, psychedelic researcher, and a builder of virtual and in-person communities. She began researching MDMA in 2004 and has worked on studies of psychedelics and mental health conditions at universities, NIH, and MAPS.

Safety 52

Safety Medicine Therapy Research and Development 52

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. The company’s analysis of the collected data yielded several insights. Every major professional sport is undergoing an analytics revolution. The Upshot.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

JULY 19, 2021

Virginia is committed to legalizing cannabis the right way—by learning from other states, by listening to public health and safety experts, and by centering social equity,” said Governor Northam. Creighton of Richmond, Co-Founder, The Jackson Ward Collective. On July 1, recreational marijuana became legal for adult use in Virginia.

Legalization 81

Legalization Research and Development Safety Advocacy 81

Veriheal

DECEMBER 23, 2022

Researchers Inspected Cannabis Products for Contaminants. Dr. Maxwell’s team also collected data contained in samples sourced from California. There was more inconsistency in cannabis-borne contaminant regulation as compared with other agricultural commodities,” wrote the researchers. As per the results, 2.3% for extracts.

Research and Development 96

Research and Development Agriculture Data Extraction 96

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome.

Safety 52

Safety Cannabinoids Events Data 52

Veriheal

AUGUST 24, 2022

Activists collected over 100,000 more signatures than needed to qualify the measure for the ballot, showing significant support for its passing. In a statement to The Denver Post, Natural Medicine Colorado—which sponsored the act—said “the measure is designed to prioritize mental health and healing, while balancing safety and access.”

Legalization 111

Legalization Decriminalization Medicine Research and Development 111

Cannabis Law Report

DECEMBER 9, 2021

The study flagship site will be at John Hopkins University (JHU) with research led by Dr. Matthew Johnson. The Company believes the safety and efficacy data collected from the NIDA grant study will support the outcome of their phase 2/3 smoking cessation clinical trial. Advancements in IP and Drug Development.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Otherside Farms

JUNE 25, 2019

Boost Government Revenue Collection. When compounded, such a new opportunity will foster nation-wide development. Gangs develop when bad laws discourage consumers from receiving products and services they need. Promote Consumer Safety. Foster Medical Research. Mitigate Violence. You cannot control what you fight.

Legalization 81

Legalization Marijuana Research and Development Chronic Pain 81

Cannabis Law Report

MAY 9, 2022

Preferred candidates will have seven years prior experience in a policy-related management role; experience with professional exposure to the cannabis industry or policy issues related to public health and safety; experience with a strong analytical background and experience working with large data sets.

Policy 52

Policy Research and Development Safety Data 52

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

JUNE 19, 2022

Partnership will focus on the collection and analysis of digital biomarkers to identify signs of response and relapse in upcoming Phase 2 clinical trials. Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. June 14, 2022 02:00 AM Eastern Daylight Time.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

Cannabis Law Report

JANUARY 12, 2022

Through this collaboration, the NPA and Maya will offer both the education and the technology infrastructure needed to make this possible, ensuring accessibility and safety to all communities. “We The Maya platform empowers psychedelic researchers, providers, and participants to collectively chart psychedelic best practices.

Research and Development 52

Research and Development Therapy Clinical Trials Safety 52

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 Effective, most effective in treatment Relieve symptoms.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

The Blunt Truth

AUGUST 13, 2019

The following is a brief update on recent developments within the federal regulatory regime of CBD products. . On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. FDA’s Regulatory Efforts.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

JULY 28, 2021

MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics prioritizing public benefit above profit. Support Regulatory Affairs in the planning, development, and publishing of submissions.

Clinical Trials 81

Clinical Trials Research and Development Data Environment 81

Veriheal

JULY 27, 2020

FOCUS Keeps An Eye On Standard Development. FOCUS is an organization concerned with the development of standards of quality within the cannabis industry—a tough topic since there is currently no federal oversight. This nonprofit collects journal articles and materials for its member’s edification.

Research and Development 64

Research and Development Chronic Pain Education Advocacy 64

Cannabis Law Report

AUGUST 27, 2021

Built on a foundation of regulatory compliance and human safety, HempFusion Wellness offers a diverse product portfolio comprising of over 75 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. FORWARD-LOOKING STATEMENTS.

Research and Development 81

Research and Development Events Hemp Food 81

SpeedWeed

MARCH 23, 2021

This warning was based on the findings of a research study suggesting that THC can remain in breast milk for as long as six days after consumption of cannabis, and this cannabinoid can be passed from mother to infant. But other than the AAP study, there has been little research into exactly how long cannabinoids can remain in breast milk.

THC 52

THC Research and Development Cannabinoids Sleep 52

Cannabis Law Report

JUNE 22, 2022

“The hemp industry is at a critical point where we need regulators and policy makers to recognize the existing, well documented science surrounding the safety and efficacy around hemp ingredients for feed. with more than 50,000 supporters and members, is dedicated to the development of the domestic hemp industry.

Hemp 52

Hemp Advocacy Research and Development Agriculture 52

Medicinal Genomics

JANUARY 10, 2024

CannMed started in 2016, when Medicinal Genomics partnered with Dr. Raphael Mechoulam to host the leading researchers and clinicians in cannabinoid medicine at Boston’s Harvard Medical School. Look no further than the CannMed Advisory Board for evidence that the most esteemed clinicians and researchers make the trip to CannMed each year.

Research and Development 52

Research and Development Events Education Medicine 52

Cannabis Law Report

MARCH 26, 2022

With five guiding objectives, the commission will reportedly consider the UK’s cannabis industry’s entire supply chain from cultivation, research and development to product development and manufacturing and sales. The final report will outline how the UK can become a global leader in cannabinoid research and innovation.

Cannabinoids 52

Cannabinoids Research and Development Supply Chain Policy 52